BVS
Bioventus Inc.
Medical Devices · Healthcare · United States
14.87
close · 2026-10-29
value
47
cheaper than peers47
quality
65
stronger fundamentals65
ranked against
Medical Devices
value
quality
84 peerswide variation
Value inputs
| measure | company | vs peers |
| cash flow yield, latest year | 6.0% | 86 |
| forward P/E | 16.16× | 77 |
| price to sales | 1.79× | 70 |
| cash flow yield, 1 year ago | 3.2% | 68 |
| earnings yield, latest year | 2.3% | 68 |
| EV to EBITDA | 14.96× | 58 |
| cash flow yield, 2 years ago | 0.7% | 41 |
| price to book | 4.44× | 38 |
| cash flow yield, 3 years ago | -1.3% | 32 |
| earnings yield, 1 year ago | -3.6% | 32 |
| earnings yield, 2 years ago | -17.5% | 14 |
| earnings yield, 3 years ago | -18.2% | 14 |
12 of 12 measures available
Quality inputs
| measure | company | vs peers |
| return on equity | 16.5% | 88 |
| operating margin | 6.7% | 75 |
| revenue growth | 6.6% | 48 |
| debt to equity | 123.1% | 26 |
4 of 4 measures available
Facts
| market cap | $1B |
| free cash flow | $63.3M |
| employees | 940 |
| first trade | 2021-02-11 |
| next earnings | 2026-11-02 |
| fundamentals updated | 2026-08-05 |
Annual history
| measure | 2025 | 2024 | 2023 | 2022 |
| diluted eps | 0.33 | -0.52 | -2.49 | -2.59 |
| free cash flow | $72.1M | $37.8M | $8.0M | -$15.0M |
| net income | $22.7M | -$36.1M | -$156.2M | -$158.7M |
| revenue | $568.1M | $573.3M | $512.3M | $512.1M |
| unusual items | -$2.6M | -$38.0M | -$83.8M | -$132.6M |